Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Its one of the most popular weight loss medications out there
A weekly self-injectable treatment available in the UK via online consultation
Inclusion Criteria Exclusion Criteria Timeline for a Trial Participant Screening Participants are screened for eligibility to participate in the trial Treatment Participants receive once-weekly subcutaneous injections of CagriSema or placebo for up to 40 weeks, with dose escalation periods for active comparators Follow-up Participants are monitored for safety and effectiveness after treatment What Are the Treatments Tested in This Trial
If your insurance doesnt cover GLP-1 medications, dont give up there are still other paths to consider
